News
-
-
PRESS RELEASE
EQS-Adhoc: Allgeier SE: Allgeier meets its earnings guidance for 2025 and is strengthening its focus on AI-based platform technologies and software solutions
Allgeier SE meets 2025 earnings guidance, focuses on AI-based technologies & software solutions. Confirms 2026 outlook with revenue expected between EUR 350-390 million -
PRESS RELEASE
Postponement of the Publication Date of the Annual Financial Statements
Ethero postpones the publication of its 2025 annual financial statements to April 9, 2026, due to discussions on financial engineering transactions accounting treatment. Company transitioning towards decentralized finance and real-world asset tokenization -
-
-
PRESS RELEASE
CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
CTS EVENTIM surpasses EUR 3 billion in revenue for the first time in 2025 with strong growth in ticketing and live entertainment segments. Company invests in technology and AI for future expansion -
-
-
PRESS RELEASE
Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed -
PRESS RELEASE
EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Leifheit Aktiengesellschaft proposes capital increase from own funds followed by capital reduction to Annual General Meeting. Measures aim to convert restricted capital surplus into distributable equity
